Cargando…

An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome

BACKGROUND: The prevalence of chronic diseases such as cancer, type 2 diabetes, metabolic syndrome (MetS), and cardiovascular disease increases with age in all populations. Epigenetic features are hypothesized to play important roles in the pathophysiology of age-associated diseases, but a map of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Omar, Cerjak, Diana, Kent, Jack W, James, Roland, Blangero, John, Carless, Melanie A, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372177/
https://www.ncbi.nlm.nih.gov/pubmed/25806089
http://dx.doi.org/10.1186/s13148-015-0048-6
_version_ 1782363135803392000
author Ali, Omar
Cerjak, Diana
Kent, Jack W
James, Roland
Blangero, John
Carless, Melanie A
Zhang, Yi
author_facet Ali, Omar
Cerjak, Diana
Kent, Jack W
James, Roland
Blangero, John
Carless, Melanie A
Zhang, Yi
author_sort Ali, Omar
collection PubMed
description BACKGROUND: The prevalence of chronic diseases such as cancer, type 2 diabetes, metabolic syndrome (MetS), and cardiovascular disease increases with age in all populations. Epigenetic features are hypothesized to play important roles in the pathophysiology of age-associated diseases, but a map of these markers is lacking. We searched for genome-wide age-associated methylation signatures in peripheral blood of individuals at high risks for MetS by profiling 485,000 CpG sites in 192 individuals of Northern European ancestry using the Illumina HM450 array. Subjects (ages 6–85 years) were part of seven extended families, and 73% of adults and 32% of children were overweight or obese. RESULTS: We found 22,122 genome-wide significant age-associated CpG sites (P(α=0.05) = 3.65 × 10(−7) after correction for multiple testing) of which 14,155 are positively associated with age while 7,967 are negatively associated. By applying a positional density-based clustering algorithm, we generated a map of epigenetic ‘hot-spots’ of age-associated genomic segments, which include 290 age-associated differentially methylated CpG clusters (aDMCs), of which 207 are positively associated with age. Gene/pathway enrichment analyses were performed on these clusters using FatiGO. Genes localized to both the positively (n = 241) and negatively (n = 16) age-associated clusters are significantly enriched in specific KEGG pathways and GO terms. The most significantly enriched pathways are the hedgehog signaling pathway (adjusted P = 3.96 × 10(−3)) and maturity-onset diabetes of the young (MODY) (adjusted P = 6.26 × 10(−3)) in the positive aDMCs and type I diabetes mellitus (adjusted P = 3.69 × 10(−7)) in the negative aDMCs. We also identified several epigenetic loci whose age-associated change rates differ between subjects diagnosed with MetS and those without. CONCLUSION: We conclude that in a family cohort at high risk for MetS, age-associated epigenetic features enrich in biological pathways important for determining the fate of fat cells and for insulin production. We also observe that several genes known to be related to MetS show differential epigenetic response to age in individuals with and without MetS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0048-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4372177
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43721772015-03-25 An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome Ali, Omar Cerjak, Diana Kent, Jack W James, Roland Blangero, John Carless, Melanie A Zhang, Yi Clin Epigenetics Research BACKGROUND: The prevalence of chronic diseases such as cancer, type 2 diabetes, metabolic syndrome (MetS), and cardiovascular disease increases with age in all populations. Epigenetic features are hypothesized to play important roles in the pathophysiology of age-associated diseases, but a map of these markers is lacking. We searched for genome-wide age-associated methylation signatures in peripheral blood of individuals at high risks for MetS by profiling 485,000 CpG sites in 192 individuals of Northern European ancestry using the Illumina HM450 array. Subjects (ages 6–85 years) were part of seven extended families, and 73% of adults and 32% of children were overweight or obese. RESULTS: We found 22,122 genome-wide significant age-associated CpG sites (P(α=0.05) = 3.65 × 10(−7) after correction for multiple testing) of which 14,155 are positively associated with age while 7,967 are negatively associated. By applying a positional density-based clustering algorithm, we generated a map of epigenetic ‘hot-spots’ of age-associated genomic segments, which include 290 age-associated differentially methylated CpG clusters (aDMCs), of which 207 are positively associated with age. Gene/pathway enrichment analyses were performed on these clusters using FatiGO. Genes localized to both the positively (n = 241) and negatively (n = 16) age-associated clusters are significantly enriched in specific KEGG pathways and GO terms. The most significantly enriched pathways are the hedgehog signaling pathway (adjusted P = 3.96 × 10(−3)) and maturity-onset diabetes of the young (MODY) (adjusted P = 6.26 × 10(−3)) in the positive aDMCs and type I diabetes mellitus (adjusted P = 3.69 × 10(−7)) in the negative aDMCs. We also identified several epigenetic loci whose age-associated change rates differ between subjects diagnosed with MetS and those without. CONCLUSION: We conclude that in a family cohort at high risk for MetS, age-associated epigenetic features enrich in biological pathways important for determining the fate of fat cells and for insulin production. We also observe that several genes known to be related to MetS show differential epigenetic response to age in individuals with and without MetS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-015-0048-6) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-20 /pmc/articles/PMC4372177/ /pubmed/25806089 http://dx.doi.org/10.1186/s13148-015-0048-6 Text en © Ali et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ali, Omar
Cerjak, Diana
Kent, Jack W
James, Roland
Blangero, John
Carless, Melanie A
Zhang, Yi
An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome
title An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome
title_full An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome
title_fullStr An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome
title_full_unstemmed An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome
title_short An epigenetic map of age-associated autosomal loci in northern European families at high risk for the metabolic syndrome
title_sort epigenetic map of age-associated autosomal loci in northern european families at high risk for the metabolic syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372177/
https://www.ncbi.nlm.nih.gov/pubmed/25806089
http://dx.doi.org/10.1186/s13148-015-0048-6
work_keys_str_mv AT aliomar anepigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT cerjakdiana anepigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT kentjackw anepigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT jamesroland anepigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT blangerojohn anepigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT carlessmelaniea anepigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT zhangyi anepigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT aliomar epigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT cerjakdiana epigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT kentjackw epigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT jamesroland epigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT blangerojohn epigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT carlessmelaniea epigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome
AT zhangyi epigeneticmapofageassociatedautosomallociinnortherneuropeanfamiliesathighriskforthemetabolicsyndrome